Back to calendar
Entrada Therapeutics, Inc. (TRDA) Earnings
TRDA reports earnings on Tuesday, November 10, 2026
earnings report
November 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $-1.01
Actual EPS: $-1.01
EPS surprise: -3.72%
Company overview
Market Cap$272.6M
PriceUSD 7.00
EPS (TTM)-3.97
52-week high16.45
52-week low5.02
SectorHealth Technology
IndustryBiotechnology
Employees152